Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 759610, 8 pages
http://dx.doi.org/10.1155/2015/759610
Clinical Study

Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis

1Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Ulica Szaserów 128, 04-141 Warszawa, Poland
2Department of Infectious Diseases and Allergology, Military Institute of Medicine, Ulica Szaserów 128, 04-141 Warszawa, Poland
3Department of Radiology, Military Institute of Medicine, Ulica Szaserów 128, 04-141 Warszawa, Poland
4Department of Medical Genetics, Medical University in Warsaw, Ulica Pawińskiego 3c, 02-106 Warszawa, Poland

Received 10 September 2014; Revised 16 January 2015; Accepted 20 January 2015

Academic Editor: Clelia M. Riera

Copyright © 2015 Bartłomiej Kisiel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Aviña-Zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile, and D. Lacaille, “Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies,” Arthritis Care & Research, vol. 59, no. 12, pp. 1690–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Maradit-Kremers, P. J. Nicola, C. S. Crowson, K. V. Ballman, and S. E. Gabriel, “Cardiovascular death in rheumatoid arthritis: a population-based study,” Arthritis & Rheumatism, vol. 52, no. 3, pp. 722–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Shoenfeld, R. Gerli, A. Doria et al., “Accelerated atherosclerosis in autoimmune rheumatic diseases,” Circulation, vol. 112, no. 21, pp. 3337–3347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. D. del Rincón, K. Williams, M. P. Stern, G. L. Freeman, and A. Escalante, “High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional cardiac risk factors,” Arthritis & Rheumatology, vol. 44, no. 12, pp. 2737–2745, 2001. View at Google Scholar
  5. I. del Rincón, G. L. Freeman, R. W. Haas, D. H. O'Leary, and A. Escalante, “Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis,” Arthritis and Rheumatism, vol. 52, no. 11, pp. 3413–3423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Naranjo, T. Sokka, M. A. Descalzo et al., “Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study,” Arthritis Research & Therapy, vol. 10, no. 2, article R30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Banks, J. Flint, P. A. Bacon, and G. D. Kitas, “Rheumatoid arthritis is an independent risk factor for ischaemic heart disease,” Arthritis and Rheumatism, vol. 43, supplement 9, article S385, 2000. View at Google Scholar
  8. M. W. Lorenz, H. S. Markus, M. L. Bots, M. Rosvall, and M. Sitzer, “Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis,” Circulation, vol. 115, no. 4, pp. 459–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. Lekakis, C. M. Papamichael, A. T. Cimponeriu et al., “Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis,” American Journal of Cardiology, vol. 85, no. 8, pp. 949–952, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Södergren, K. Karp, K. Boman et al., “Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness,” Arthritis Research & Therapy, vol. 12, no. 4, article R158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Adhikari, A. Guin, S. Chakraborty, P. Sinhamahapatra, and A. Ghosh, “Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study,” Seminars in Arthritis & Rheumatism, vol. 41, no. 5, pp. 669–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Kocabay, H. Hasdemir, and M. Yildiz, “Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behçet's disease,” Journal of Cardiology, vol. 59, no. 1, pp. 72–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. V. Veselinovic, V. I. Zivkovic, S. Toncev et al., “Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis,” Vasa, vol. 41, no. 5, pp. 343–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hannawi, B. Haluska, T. H. Marwick, and R. Thomas, “Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation,” Arthritis Research and Therapy, vol. 9, no. 6, article R116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. N. Tyrrell, J. Beyene, B. M. Feldman, B. W. McCrindle, E. D. Silverman, and T. J. Bradley, “Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 5, pp. 1014–1026, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lahiri, C. Morgan, D. P. M. Symmons, and I. N. Bruce, “Modifiable risk factors for RA: prevention, better than cure?” Rheumatology, vol. 51, no. 3, Article ID ker299, pp. 499–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. F. van Breukelen-van der Stoep, B. Klop, D. van Zeben, J. M. W. Hazes, and M. C. Cabezas, “Cardiovascular risk in rheumatoid arthritis: how to lower the risk?” Atherosclerosis, vol. 231, no. 1, pp. 163–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stavropoulos-Kalinoglou, G. S. Metsios, V. F. Panoulas et al., “Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 68, no. 2, pp. 242–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. J. Armstrong, E. M. McCausland, A. D. Quinn, and G. D. Wright, “Obesity and cardiovascular risk factors in rheumatoid arthritis,” Rheumatology, vol. 45, no. 6, pp. 782–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. M. Kremers, P. J. Nicola, C. S. Crowson, K. V. Ballman, and S. E. Gabriel, “Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3450–3457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. H. Dessein, B. I. Joffe, M. G. Veller et al., “Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis,” Journal of Rheumatology, vol. 32, no. 3, pp. 435–442, 2005. View at Google Scholar · View at Scopus
  22. Y. B. Park, S. K. Lee, W. K. Lee et al., “Lipid profiles in untreated patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 26, no. 8, pp. 1701–1704, 1999. View at Google Scholar · View at Scopus
  23. E. Myasoedova, C. S. Crowson, H. M. Kremers et al., “Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease,” Annals of the Rheumatic Diseases, vol. 70, no. 3, pp. 482–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. B. H. Hahn, J. Grossman, W. Chen, and M. McMahon, “The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia,” Journal of Autoimmunity, vol. 28, no. 2-3, pp. 69–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Choy, K. Ganeshalingam, A. G. Semb, Z. Szekanecz, and M. Nurmohamed, “Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment,” Rheumatology, vol. 53, no. 12, pp. 2143–2154, 2014. View at Publisher · View at Google Scholar
  26. S. Wållberg-Jonsson, H. Johansson, M.-L. Öhman, and S. Rantapää-Dahlqvist, “Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset,” Journal of Rheumatology, vol. 26, no. 12, pp. 2562–2571, 1999. View at Google Scholar · View at Scopus
  27. L. Innala, B. Möller, L. Ljung et al., “Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study,” Arthritis Research and Therapy, vol. 13, no. 4, article R131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Crilly, V. Kumar, H. J. Clark, N. W. Scott, A. G. MacDonald, and D. J. Williams, “Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors,” Rheumatology (Oxford), vol. 48, no. 12, pp. 1606–1612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, A. Piñeiro, C. Garcia-Porrua, A. Testa, and J. Llorca, “High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 32, no. 7, pp. 1219–1223, 2005. View at Google Scholar · View at Scopus
  30. I. Del Rincón, K. Williams, M. P. Stern, G. L. Freeman, D. H. O'Leary, and A. Escalantel, “Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects,” Arthritis and Rheumatism, vol. 48, no. 7, pp. 1833–1840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Hannawi, T. H. Marwick, and R. Thomas, “Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis,” Arthritis Research & Therapy, vol. 11, no. 2, article R51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. M. Mäki-Petäjä, F. C. Hall, A. D. Booth et al., “Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy,” Circulation, vol. 114, no. 11, pp. 1185–1192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. W. Jonsson, C. Backman, O. Johnson et al., “Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis,” The Journal of Rheumatology, vol. 28, no. 12, pp. 2597–2602, 2001. View at Google Scholar · View at Scopus
  34. A. Sandoo, N. Chanchlani, J. Hodson, J. P. Smith, K. M. Douglas, and G. D. Kitas, “Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study,” Arthritis Research and Therapy, vol. 15, no. 6, article R203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Scarno, F. M. Perrotta, F. Cardini et al., “Beyond the joint: subclinical atherosclerosis in rheumatoid arthritis,” World Journal of Orthopaedics, vol. 5, no. 3, pp. 328–335, 2014. View at Publisher · View at Google Scholar
  36. H. K. Choi, M. A. Hernán, J. D. Seeger, J. M. Robins, and F. Wolfe, “Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study,” The Lancet, vol. 359, no. 9313, pp. 1173–1177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. L. Westlake, A. N. Colebatch, J. Baird et al., “The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review,” Rheumatology, vol. 49, no. 2, pp. 295–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Chatterjee, P. Sarkate, S. Ghosh, M. Biswas, and A. Ghosh, “Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis-a single centre study using non-biologic drugs,” Journal of Association of Physicians of India, vol. 61, no. 8, pp. 531–534, 2013. View at Google Scholar · View at Scopus
  39. A. Guin, M. C. Adhikari, S. Chakraborty, P. Sinhamahapatra, and A. Ghosh, “Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study,” Seminars in Arthritis and Rheumatism, vol. 43, no. 1, pp. 48–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Kerekes, P. Soltész, G. Szücs et al., “Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis,” Israel Medical Association Journal, vol. 13, no. 3, pp. 147–152, 2011. View at Google Scholar · View at Scopus
  41. K. Angel, S. A. Provan, M. K. Fagerhol, P. Mowinckel, T. K. Kvien, and D. Atar, “Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study,” American Journal of Hypertension, vol. 25, no. 6, pp. 644–650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez, J. A. Miranda-Filloy et al., “Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy,” Mediators of Inflammation, vol. 2012, Article ID 674265, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. L. Westlake, A. N. Colebatch, J. Baird et al., “Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review,” Rheumatology, vol. 50, no. 3, pp. 518–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. T. Giles, W. S. Post, R. S. Blumenthal et al., “Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 63, no. 11, pp. 3216–3225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. J. D. Greenberg, J. M. Kremer, J. R. Curtis et al., “Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 4, pp. 576–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. B. D'Agostino Sr., R. S. Vasan, M. J. Pencina et al., “General cardiovascular risk profile for use in primary care: the Framingham heart study,” Circulation, vol. 117, no. 6, pp. 743–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. V. P. van Halm, M. J. L. Peters, A. E. Voskuyl et al., “Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation,” Annals of the Rheumatic Diseases, vol. 68, no. 9, pp. 1395–1400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. M. van Sijl, M. J. Peters, D. K. Knol et al., “Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis,” Seminars in Arthritis and Rheumatism, vol. 40, no. 5, pp. 389–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Danesh, P. Whincup, M. Walker et al., “Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses,” British Medical Journal, vol. 321, no. 7255, pp. 199–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Barnabe, B.-J. Martin, and W. A. Ghali, “Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis,” Arthritis Care & Research, vol. 63, no. 4, pp. 522–529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. W. G. Dixon, K. D. Watson, M. Lunt et al., “Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 2905–2912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Oryoji, C. Kiyohara, T. Horiuchi et al., “Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A,” Modern Rheumatology, vol. 24, no. 1, pp. 86–92, 2014. View at Google Scholar
  53. M. L. Bots, A. W. Hoes, P. J. Koudstaal, A. Hofman, and D. E. Grobbee, “Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study,” Circulation, vol. 96, no. 5, pp. 1432–1437, 1997. View at Publisher · View at Google Scholar · View at Scopus